ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2125

Comparison Of The Effectiveness Of Local Anesthetic and Corticosteroid Injections For The Treatment Of Piriformis Syndrome

Tugce Ozekli Misirlioglu, Kenan Akgun, Meryem Gul Erden and Tuba Erbilir, Physical Medicine and Rehabilitation, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Low back pain, sciatica and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: Abstract Submissions (ACR)

Background/Purpose: Piriformis syndrome (PS), which is characterized by pain radiating to gluteal region and posterior leg, is accepted as one of the causes of sciatica. Although the importance of local piriformis muscle injections whenever PS is clinically suspected has been shown in many studies, there is not enough study considering the clinical efficacy of these injections. The objective of this study was to compare the effectiveness of ultrasound (US)-guided local anesthetic (LA) and corticosteroid (CS) injections for the treatment of PS.

Methods: Fifty-seven patients with a pre-diagnosis of PS after clinical evaluation were included in this prospective randomized double-blind study. After baseline assessments that were done by the first physiatrist, subjects who were blinded to group allocation, were randomized by the second physiatrist. US-guided injections of 4 cc of lidocaine 2% (LA group) and 4 cc of lidocaine 2%+1 cc of betametazone dipropionate (LA+CS group) with a 22-gauge 88 mm Spinocan were done by the third physiatrist with a Diasus dynamic imaging US equipped with a 5- to 10- MHz multifrequency transducer. The patients whose pain resolved 50% and more were included in the study. Seven patients whose injection tests were negative were excluded from the study. Each group contained 25 patients with a diagnosis of PS. The subjects were re-assessed by the first physiatrist with physical examination and Likert Analogue Scale (LAS) and Numeric Rating Scale (NRS) at the 1st week, the 1st and 3rd months after the injection.  

Results: The difference between two groups was analyzed with Pillai’s Trace, which is a multivariate analysis from general linear models. No statistically significant difference (p>0,05)  was detected between the groups in NRS score values at resting (p=0.814), night (p=0.830) and in motion (p=0.145) and LAS values with long duration of sitting (p=0.547), standing (p=0.898) and lying (p=0.326) with evaluations at the baseline, 1st week, 1st and 3rd months after the injection. Each group was compared within itself by Friedman test, which is used for non-parametric repeated measures. A statistically highly significant (p<0,005) reduction of pain was evaluated through NRS scores at resting (p=0.001), in motion (p=0.001)  and at night (p=0.001) and and LAS values with long duration of sitting (p=0.001), standing (p=0.001) and lying (p=0.001) in both of the groups. 

Conclusion: LA injections for the PS were found to be clinically effective. However, addition of CS to LA did not give an additional benefit. This gives us the idea that PS has similar features with the other myofascial pain syndromes and responds well to trigger point injections.


Disclosure:

T. Ozekli Misirlioglu,
None;

K. Akgun,
None;

M. G. Erden,
None;

T. Erbilir,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-the-effectiveness-of-local-anesthetic-and-corticosteroid-injections-for-the-treatment-of-piriformis-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology